Related Experiment Video
Updated: Sep 16, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Epigenetic therapeutics: reprogramming triple-negative breast cancer into responsive subtypes
Triple negative breast cancer (TNBC) is aggressive. Epigenetic drugs can reprogram TNBC cells into less aggressive subtypes, improving treatment effectiveness and patient outcomes.
Area of Science:
- Oncology
- Epigenetics
- Genomics
Background:
- Triple negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies.
- TNBC exhibits high plasticity, contributing to therapeutic challenges.
- Epigenetic mechanisms, including DNA methylation and histone modifications, are implicated in TNBC progression.
Purpose of the Study:
- To review the role of epigenetic modulation in TNBC subtype conversion.
- To explore the potential of epigenetic drugs (epidrugs) in enhancing TNBC treatment.
- To discuss challenges and limitations of using epidrugs for TNBC.
Main Methods:
- Review of existing literature on epigenetic mechanisms in TNBC.
- Analysis of how epigenetic drugs target enzymes like DNA methyltransferases and histone modifiers.
- Discussion of TNBC plasticity and subtype reprogramming strategies.
Main Results:
- Epigenetic modulation can reprogram TNBC into less aggressive, more treatable subtypes.
- Epidrugs can resensitize TNBC cells to conventional therapies like hormone therapy and chemotherapy.
- Harnessing TNBC plasticity via epigenetics offers a novel therapeutic avenue.
Conclusions:
- Epigenetic reprogramming is a promising strategy for treating aggressive TNBC.
- Epidrugs hold potential for personalized and effective TNBC therapies.
- Further research is needed to address limitations and optimize epidrug use in TNBC treatment.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming
Somatic to iPS Cell Reprogramming
Epigenetic Regulation
X-chromosome...